Inhibitory effects of centrally administered somatostatin on the adrenal zona glomerulosa in male rats

Pharmacology

Volumn 53, Issue 6, 1996, Pages 369-375

  Milosevic V ^a   Velkovski, S ^b   Brkic B ^c   Sekulic M ^a   Lovren, M ^a   Starcevic V ^b   Severs, W B ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinical Centre ‘Dr Dragiša Mišović’ ^*  (Serbia)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Adrenal glands; Centrally administered somatostatin; Inhibitory effect; Zona glomerulosa

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; GROWTH HORMONE; HYPOPHYSIS HORMONE; PROLACTIN; SOMATOSTATIN;

ADRENAL GLAND; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; GROWTH; GROWTH HORMONE BLOOD LEVEL; HISTOLOGY; HORMONE BLOOD LEVEL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; STEREOLOGY; STEROIDOGENESIS; ZONA GLOMERULOSA;

ALDOSTERONE; ANIMALS; GROWTH HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; PITUITARY-ADRENAL SYSTEM; PROLACTIN; PROTEIN PRECURSORS; RATS; RATS, WISTAR; SOMATOSTATIN; SOMATOSTATIN-28; ZONA GLOMERULOSA;

EID: 0030465214     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139452     Document Type: Article

References (39)

1. Epclbaum J. Dournaud P. Fodor M. Violici C: The neurobiology of somatostatin. Crit Rev Neurobiol 1994:8:25-44.
2. Reichlin S: Somatostatin. N Engl J Med 1983:309:1495-1501, 1556-1563.
3. Priestley JW. Rethclyi M. Lund PK: Semiquantitative analysis of somatostatin mRNA distribution in the rat central nervous system using in situ hybridization. J Chem Ncuroanat 1991:4:131-140.
4. Mengod G. Rigo M. Savasta M. Probst A. Palacios JM: Regional distribution of neuropeptide somatostatin gene expression in the human brain. Synapse 1992:12:62-69.
5. Harmar AJ: Neuropeptides. Basic Clin Aspects Neurosci 1987;2:17-26.
6. Patel YC: General aspects of the biology and function of somatostatin. Basic Clin Aspects Neurosci 1992:4: 1-16.
7. Arnold R, Linkisch BG: Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1980:9:733-753.
8. Lamberts SJ. Krenning EP. Rcubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991; 12:450-482.
9. Patel YC. Greenwood R. Panetta R. Dcmchyshyn L. Niznik H, Srikant CB: The somatostatin receptor family. Life Sci 1995:57:1249-1265.
10. Raulf F. Perez J. Hoyer D. Bruns C: Differential expression of live somatostatin receptor subtypes. SSTRI-5. in the CNS and peripheral tissue. Digestion 1994:55:46-53.
11. Aguilera G. Harwood PJ. C'att KJ: Somatostatin modulates effects of angiotensin 11 in adrenal glomcrulo-sa zone. Nature 1981:292:262-263.
12. Mazzocchi G. Robba C. RebulTat P. Gottardo G, Nussdorfer G: Effect of somatostatin on the zona glomerulo-sa of rats treated with angiotensin 11 or captopril: Stcreology and plasma hormone concentrations. J Steroid Biochcm 1985:3:353-356.
13. Robba C. Mazzocchi G. Nussdorfer G: Further studies on the inhibitory effects of somatostatin on the growth and steroidogenic capacity of rat adrenal zona glomcrulosa. Exp Pathol 1986:29:77-82.
14. RcbulTat P, Belloni SA, Musajo FG. Rocco S. Markowska A. Mazzocchi G, Nussdorfcr GG: Evidence lhal endogenous somatostatin (SRIF) exerts an inhibitors' control on the function and growth of rat adrenal zona glomcrulosa: The possible involvement of zona medullaris as a source of endogenous SR IF. J Steroid Biochcm Mol Biol 1994:48: 353-360.
15. Ganong WF. Dallman MF, Roberts JL: The hypothalamic-pituitary adrenal axis revisited. Ann NY. Acad Sci 1987:512:1-51.
16. Startcvic VP. Morrow BA. Farner LA. Keil LC. Severs WB: Long-term recording of cerebrospinal fluid pressure in freely behaving rats. Brain Res 1988;462:112-117.
17. Weibel ER. Gomez DM: A principle for count ing tissue structures on random sections. J Appl Physiol 1962: 17:343-348.
18. Swinyard CA: Methods for volumetric determination of fresh endocrine glands. Anal Rec 1938;74:71-78.
19. Malcndow icz LK: Sex differences in adrenocortical structure and function. I. The effects of postpubertal gonadectomy and gonadal hormone replacement in nuclear volume of adrenocortical cells in the rat. Cell Tissue Res 1974:151:525-536.
20. Kasprzak A. Rcbuffa! P. Andreis PG. Mazzocchi G, Nussdorfcr GG: Effects of prolonged evsteamine administration on the rat adrenal cortex: Evidence that endogenous somatostatin is involved in the control of the growth and steroidogenic capacity of zona glomcrulosa. J Steroid Biochem Mol Biol 1991:38: 469-473.
21. Rebuffat P. Robba C. Mazzocchi G. Nussdorfcr GG: Inhibitory effect of somatostatin on the growth and steroidogenic capacity of rat adrenal glomerulosa. J Steroid Biochem 1984:21:387-390.
22. Srikant CB. Patel YC: Somatostatin receptors in the rat adrenal cortex: Comparison with brain and pituitary receptors. Endocrinology 1985; 116:1717-1723.
23. Maurer R, Rcubi JC: Somatostatin receptors in adrenal. Mol Cell Endocrinol 1986:45:81-90.
24. Morel G. Leroux P, Caballero G. Beiras A. Gossard F: Ultrastructural distribution of somatostatin-14 and-28 in rat adrenal cells. Cell Tissue Res 1990:261:517-524.
25. Pelto-Huikko M: Correlative microscopy of catecholamines and neuropeptides in adrenal medulla: in Hayat MA (ed): Correlative Microscopy in Biology: Instrumentation and Methods. New York. Academic Press. 1987. pp 143-155.
26. Lee Y-J. Lin S-R. Shin S-J. Lai Y-U, Lin Y-T. Tsa J-H: Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism. J Clin Endocrinol Metab 1994:79:1476-1482.
27. Einer-Jenscn N, Carter AM: Local transfer of hormones between blood vessels within the adrenal gland may explain the functional interaction between the adrenal cortex and medulla. Med Hypotheses 1995:44: 471-474.
28. Yamaguchi T. Baba K. Doi Y. Yano K: Effects of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomcrulosa cells. Life Sci 1995:56:379-387.
29. Cooper JR. Bloom FF. Roh RH: The Biochemical Basis of Neuropharmacology. London, Oxford University Press. 1991. pp 381-427.
30. Nieman LL, Loriaux DL. Chrousos GP: Corticotropin-releasing factors: in Cohen MP. Foa PP (eds): The Brain as an Endocrine Organ. New York, Springer. 1989. vol 3, pp 14-45.
31. Eldridge JC. Lymangrover J R: Prolactin stimulates and potentiates adrenal steroid secretion in vitro. Horm Res 1984:20:252-260.
32. Mazzocchi G. Robba C. Rcbuffal P. Nussdorfcr G: Effects of prolactin administration on the zona glomcrulosa of the rat adrenal cortex: Stc-rcology and plasma hormone concentrations. Acta Endocrinol (Co-penh) 1986:111:101-105.
33. RcbulTat P. Robba C. Mazzocchi G, Nussdorfcr G: Further studies on the effects of prolonged prolactin administration on the zona glomerulosa of the rat adrenal cortex. Res Exp Med(Berl) 1986:186:307-315.
34. Chiodini PG. Attanasio R, Orlandi P, Cozzi R: Growth hormone release inhibiting hormone: Basic and clinical aspects: in Motta M (cd): Brain Endocrinology. New York. Raven Press, 1991. pp 301-313.
35. Pantic V: Brain neurons, pituitary' and their target cells: Reaction to stress. GlasCCCLXVlII Acad Serbe Sci Arts 1992:56:5-29.
36. Swaab DF. Kamphorst W, Raad-sheer FC. Purba JS. Ravid R, Til-ders FHJ: Increased hypothalamo-pituitary-adrena! axis activity is not pivotal in the pathogenesis of Alzheimer's disease: in Iqbal K. Mortimer JA. Winblad B. Wisniewski HM (eds): Research Advances in Alzheimer’s Disease and Related Disorders. New York. Wiley, 1995. pp 461-466.
37. Bissctte G. Myers B: Somatostatin in Alzheimer’s disease and depression. Life Sci 1992:51:1389-1410.
38. Wehrenberg WB. Bergman PJ. Slagg L. Ndon J. Guistina A: Glucocorticoid inhibition of growth in rats: Partial reversal with somatostatin antibodies. Endocrinology 1990; 127:2705-2708.
39. Guistina A. Wehrenberg WB: The role of glucocorticoids in the regulation of growth hormone secretion: Mechanisms and clinical significance. Trends Endocrinol Mctab 1992:3:306-311.